US Federal 2025-2026 Regular Session

US Federal House Bill HB1504

Introduced
 
Introduced
2/21/25  

Caption

China Trade Relations Act of 2025

Summary

HB1504, titled the China Trade Relations Act of 2025, would end normal trade relations treatment for products of the People’s Republic of China and replace the current permanent trade status with a more restrictive framework tied to the Trade Act of 1974. The bill states that, upon enactment, China would no longer receive nondiscriminatory tariff treatment under the normal trade relations rules, and any future extension of that treatment would have to occur under the older East-West trade and human rights provisions of the Trade Act as they existed before China joined the World Trade Organization. The bill also expands the grounds on which China could be denied normal trade relations and related U.S. government benefits. It adds a long list of human rights, labor, security, and economic concerns, including prison labor, forced labor, concentration camps, harassment of overseas nationals, Tibet’s religious and cultural heritage, economic espionage, torture, detention of dissidents, access for human rights monitors, organ harvesting, and forced abortion or sterilization. The President would be required to submit periodic reports to Congress before China could regain eligibility, and the bill creates a waiver process and congressional disapproval mechanism for extending that waiver authority. In practical terms, the bill would significantly alter U.S. trade law by amending section 402 of the Trade Act of 1974 and changing the statutory table of contents to reflect a new heading, “East-West trade and human rights.” It would affect tariffs, trade preferences, and the executive branch’s ability to conclude commercial agreements with China, while also conditioning access to U.S. credit, credit guarantees, and investment guarantees on presidential findings and reporting. The measure is framed as both a trade restriction and a human-rights enforcement tool. The available context shows no committee debate or recorded votes, so there is no documented floor-level sentiment in the provided materials. Based on the bill text, the sponsor’s intent appears strongly adversarial toward current U.S.-China trade policy and highly critical of the Chinese government’s human rights and security practices. Because there are no transcripts or votes, any broader legislative support or opposition cannot be determined from the record provided. The main points of contention likely center on whether revoking normal trade relations is an effective response to China’s conduct, the economic consequences for importers and consumers, and the scope of the bill’s human rights findings. The bill’s broad list of disqualifying conditions, including allegations of concentration camps, espionage, and forced sterilization, suggests that supporters would view it as a sanctions-style response to serious abuses, while opponents may argue it could escalate trade conflict and disrupt existing commercial relationships.

Impact

The bill would amend the Trade Act of 1974 to create a new statutory basis for denying China normal trade relations and related U.S. trade and investment benefits. It would also require recurring presidential reports to Congress, establish a waiver-and-disapproval process for temporary extensions, and revise the Trade Act’s section heading and table of contents to reflect a human-rights-focused framework. If enacted, it would directly affect tariffs, trade agreements, and eligibility for U.S. government credit and investment programs involving China.

Sentiment

No committee transcripts or votes were provided, so there is no recorded legislative debate or roll-call sentiment to summarize. The bill’s text itself reflects a strongly critical posture toward the People’s Republic of China, emphasizing trade restrictions, human rights violations, labor abuses, and economic espionage. The overall tone is punitive and confrontational rather than cooperative, indicating clear support from the sponsors for a tougher trade stance.

Contention

The likely areas of contention are the economic and diplomatic consequences of withdrawing normal trade relations, the breadth of the bill’s human-rights and security findings, and the degree of discretion it gives the President through reporting and waiver authority. Supporters would likely argue that China’s alleged abuses justify trade penalties, while critics would likely focus on higher costs, retaliation risks, and whether trade restrictions are the best mechanism for addressing human rights concerns. Because no hearing or vote record is included, the specific positions of other legislators are not available.

Companion Bills

No companion bills found.

Previously Filed As

US SB3566

No Trade Preferences for Communist China Act

US HB1122

China Technology Transfer Control Act of 2025

US SB206

Restoring Trade Fairness ActThis bill establishes various trade measures related to China, including by revoking China's permanent normal trade relations (PNTR) status and increasing the rates of duty (i.e., tariffs) on Chinese imported goods. The bill prohibits imported goods originating from North Korea, China, Russia, or Iran from receiving de minimis treatment. (Current law allows for U.S. imports under a de minimis threshold of $800 per shipment to enter free of tariffs, fees, and taxes.)Specifically, the bill revokes China's PNTR status. Currently, China's PNTR status allows for Chinese goods to have duty rates set forth in column 1 of the Harmonized Tariff Schedule of the United States (HTS). With the removal of China's PNTR status, the bill generally sets the applicable duty rates on imported Chinese goods at the higher rates listed in column 2 of the HTS, with exceptions.The bill establishes a minimum duty rate of 35% for all Chinese goods, which requires column 2 rates to be at least 35%. However, the bill establishes a minimum duty rate of 100% for a list of specified goods (e.g., various minerals, certain vaccines and drugs, and certain defense-related articles). Duty rates are phased in over five years and adjusted annually for inflation.The bill alsoauthorizes the President to take additional actions related to trade with China, requires merchandise imported from China to be appraised based on U.S. value, and establishes a trust fund to compensate U.S. producers for lost revenue resulting from retaliatory actions by China.

US HB694

Restoring Trade Fairness ActThis bill establishes various trade measures related to China, including by revoking China's permanent normal trade relations (PNTR) status and increasing the rates of duty (i.e., tariffs) on Chinese imported goods. The bill prohibits imported goods originating from North Korea, China, Russia, or Iran from receiving de minimis treatment. (Current law allows for U.S. imports under a de minimis threshold of $800 per shipment to enter free of tariffs, fees, and taxes.)Specifically, the bill revokes China's PNTR status. Currently, China's PNTR status allows for Chinese goods to have duty rates set forth in column 1 of the Harmonized Tariff Schedule of the United States (HTS). With the removal of China's PNTR status, the bill generally sets the applicable duty rates on imported Chinese goods at the higher rates listed in column 2 of the HTS, with exceptions.The bill establishes a minimum duty rate of 35% for all Chinese goods, which requires column 2 rates to be at least 35%. However, the bill establishes a minimum duty rate of 100% for a list of specified goods (e.g., various minerals, certain vaccines and drugs, and certain defense-related articles). Duty rates are phased in over five years and adjusted annually for inflation.The bill alsoauthorizes the President to take additional actions related to trade with China, requires merchandise imported from China to be appraised based on U.S. value, and establishes a trust fund to compensate U.S. producers for lost revenue resulting from retaliatory actions by China.

US HB7075

Divesting from Communist China’s Military Act of 2026

US SB3640

Divesting from Communist China’s Military Act of 2026

US SB2362

Ending Lending to China Act of 2025

US HB692

China Exchange Rate Transparency Act of 2025

US HB747

Stop Chinese Fentanyl Act of 2025

US SB2146

China Exchange Rate Transparency Act of 2025

Similar Bills

No similar bills found.